CTCs TellBio, ARUP Laboratories to Explore CTC Collection Platform for Cancer Research Premium ARUP hopes to use TellBio's platform for several applications in solid tumor types, including prostate and gynecological cancers. TellBio Raises $5M in Series A Round, Inks Deals With Genetron, ARUP for Liquid Biopsy Platform The startup's strategic agreements with Genetron Holdings and ARUP Laboratories will accelerate global deployment of its TellDx liquid biopsy platform. Biocept Prepares for First FDA Foray With CSF Liquid Biopsy Brain Metastases Assay Premium The company has previously offered its liquid biopsy tests through an LDT model but sees the timing and the clinical niche as right for a regulatory bid in CSF testing. Startup MiCareo Targets Rare Cell Isolation Market With Flow Displacement Instrument Premium The Taiwan-based startup aims to publish data showing the instrument's prognostic value in colorectal cancer, as well as launch a new version, by this summer. Biocept Q4 Revenues Spike as COVID-19 Testing Continues to Soar, Core Cancer Tests Lag The firm's fourth quarter revenues included $18.3 million in commercial test revenue, of which $17.6 million was attributable to COVID-19 tests. Mar 25, 2021 Startup Tethis Targets Early-Stage Breast Cancer Detection With CTC Sample Prep Platform Premium Mar 24, 2021 Lucence, Waseda University Partner to Develop Laser-Based Liquid Biopsy Platform Mar 23, 2021 CellMax Life, Sebela Pharmaceuticals Sign Commercial Agreement for Colorectal Cancer Dx Test Mar 18, 2021 Scienion, Gilupi to Develop Circulating Tumor Cell Analysis Workflow Mar 17, 2021 Metabolic Marker Helps Identify Lung Cancer-Linked Circulating Tumor Cells Premium Mar 3, 2021 Deepcell Advancing AI-Driven Cell Morphology Tech for Single-Cell Genomics, Liquid Biopsy Premium Jan 21, 2021 OncoLab Diagnostics Targets Cancer Recurrence Monitoring with CTC-Derived Biomarker Assay Premium Dec 18, 2020 BioView, Ruby Nanomed Form Circulating Tumor Cell Analysis Partnership Dec 10, 2020 Menarini's CellSearch Shows CTCs' Potential to Predict Breast Cancer Prognosis, Treatment Response Premium Nov 19, 2020 Epic Sciences, USC Michelson Center Sign Licensing Agreement for Liquid Biopsy Research Nov 13, 2020 Biocept Eyes Neuro-Oncology for Future Liquid Biopsy Growth as Testing Lags Amid COVID Pandemic Premium Nov 9, 2020 Savran Technologies to Target Breast Cancer Recurrence with Circulating Tumor Cell Platform Premium Oct 29, 2020 Epic Sciences, Predicine to Offer Liquid Biopsy Service for Biopharma Customers Oct 9, 2020 Georgetown Team Sees Potential for Novel CTC Culture Method to Study Metastatic Cancer Premium Sep 28, 2020 Angle Files De Novo FDA Submission for CTC Collection Device in Breast Cancer Sep 10, 2020 Epic Sciences, MSK Identify Potential Prostate Cancer Therapy Response Biomarker Premium Jul 10, 2020 Presence of cfDNA, CTCs Predicts Recurrence in Triple-Negative Breast Cancer Jun 29, 2020 Creatv MicroTech Aims to Detect Patient Immune Cells for Cancer Drug Response Prediction Premium May 13, 2020 Biocept Q1 Revenues Up 41 Percent May 7, 2020 Prospective Study Adds Evidence for CellMax Life Liquid Biopsy Utility in CRC Screening Premium Load More Breaking News Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.